anidulafungin has been researched along with camostat in 1 studies
Studies (anidulafungin) | Trials (anidulafungin) | Recent Studies (post-2010) (anidulafungin) | Studies (camostat) | Trials (camostat) | Recent Studies (post-2010) (camostat) |
---|---|---|---|---|---|
568 | 33 | 331 | 337 | 14 | 93 |
Protein | Taxonomy | anidulafungin (IC50) | camostat (IC50) |
---|---|---|---|
Transmembrane protease serine 2 | Homo sapiens (human) | 0.018 | |
Prothrombin | Homo sapiens (human) | 0.399 | |
Serine protease hepsin | Homo sapiens (human) | 0.0235 | |
Trypsin-1 | Homo sapiens (human) | 0.0035 | |
Trypsin-2 | Homo sapiens (human) | 0.0035 | |
Procathepsin L | Homo sapiens (human) | 0.018 | |
Furin | Homo sapiens (human) | 0.018 | |
Trypsin-3 | Homo sapiens (human) | 0.0035 | |
Transmembrane protease serine 6 | Homo sapiens (human) | 0.018 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 2.9 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Byun, SY; Choi, I; Jeon, S; Kim, S; Ko, M; Lee, J; Park, S; Shum, D | 1 |
1 other study(ies) available for anidulafungin and camostat
Article | Year |
---|---|
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Niclosamide; Pandemics; Pneumonia, Viral; Pregnenediones; SARS-CoV-2; Vero Cells | 2020 |